Tin tức & Cập nhật

Chỉ hiển thị Multimedia
Pulmonary arterial hypertension outcomes better with early therapy augmentation with selexipag
Pulmonary arterial hypertension outcomes better with early therapy augmentation with selexipag
04 Oct 2024 bởiJairia Dela Cruz

In the treatment of patients with pulmonary arterial hypertension, adding selexipag as a third medication sooner rather than later is crucial to help prevent hospitalization and disease progression, as suggested in an emulated target trial.

Pulmonary arterial hypertension outcomes better with early therapy augmentation with selexipag
04 Oct 2024